Olivier Tak has a background in both Nanobiology and Medicine. Prior to co-initiating Curie Capital in 2018 and joining the first fund as an investment analyst, Olivier worked at De Groot Family Office as an analyst on their biotechnology portfolio. During his studies at Delft University of Technology and Erasmus Medical Center, Olivier did research at the Francis Crick Institute and Harvard Medical School. Besides his studies he conducted internships at Medicxi and Kempen & Co.